Our Biometrics organization starts with the end in mind, deconstructing the regulatory pathway to ensure the data are reported, displayed, and captured in the most appropriate manner to support our sponsor’s development process.
At PRA, Biometrics forms a centralized, global model that integrates Portfolio Management, Biostatistics and Programming, and Data Operations. Our team of top industry experts operates across all phases and PRA divisions, allowing us to easily customize our Biometrics model and provide cost-effective solutions for any client.
PRA’s 3 Chinese Biometrics hubs offer our clients the highest quality, flexible, scalable, and multilingual Biostatistics, Programming, and Data Operations services for local, regional, and global clinical studies“
Associate DirectorBiometrics, China
The centralization of PRA’s Biometrics model offers the following:
Global standards, processes, and integrated systems
Delivery with consistency, reliability, and high quality
Team allocation based on the relevant time zone and therapeutic expertise
Industry-leading data management and Clinical Data Interchange Standards Consortium (CDISC) data conversion technology (EXACT™)
PRA has 3 Biometrics hubs in China: Beijing, Shanghai, and Dalian. These hubs offer multilingual skill support for Japanese and Korean clients and leverage more effective project structures across Asia Pacific and the rest of the world. PRA’s investment and expansion in China is a direct response to our sponsors’ needs and builds on our mission to advance global clinical drug development.
Explore PRA in China
Our Solutions and Capabilities
Biometrics forms a centralized, global model that integrates Portfolio Management, Biostatistics and Programming, Data Operations, and Medical…
We support the phase II-III clinical development of niche treatments, blockbuster drugs, and biosimilars that help save lives.
Center for Rare Diseases continues to engage with rare disease patient communities during COVID-19 crisis
PRA Health Sciences’ Center for Rare Diseases is committed to engaging rare disease patient communities, and providing transparency, throughout the…
The Center for Global Drug Development
PRA’s Center for Global Drug Development assists clients in the design and execution of global drug development and asset management strategies. Our…